Histone deacetylase inhibitors sensitize glioblastoma models to temozolomide and reprogram immunosuppressive myeloid cells
Crossref DOI link: https://doi.org/10.1038/s41598-025-20749-5
Published Online: 2025-10-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tehrani, Golnaz Asaadi
Kubick, Rebecca N.
Zarodniuk, Maksym
Datta, Meenal
Text and Data Mining valid from 2025-10-21
Version of Record valid from 2025-10-21
Article History
Received: 1 May 2025
Accepted: 16 September 2025
First Online: 21 October 2025
Declarations
:
: The authors declare no competing interests.